7Baggers

We provide you with 20 years of free, institutional-grade data for ANNX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ANNX. Explore the full financial landscape of ANNX stock.

Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
NameActionSharesAvg PriceAmountReported Date
Carson William H.Open Market Purchase3,200$4.832024-06-05
Carson William H.Open Market Purchase3,200$4.682024-05-03
Carson William H.Open Market Purchase3,200$6.072024-04-10
Lew JenniferSale-2,593$5.53$14,3392024-02-21
Lew JenniferGrant, award...etc39,0002024-02-21
Dananberg JamieGrant, award...etc39,0002024-02-21
ARTIS DEAN RICHARDGrant, award...etc39,0002024-02-21
Yednock TedSale-2,604$5.51$14,3482024-02-21
Yednock TedGrant, award...etc39,0002024-02-21
Overdorf MichaelSale-1,951$5.48$10,6912024-02-21
Overdorf MichaelGrant, award...etc39,0002024-02-21
Yednock TedSale-1,810$5.54$10,0272024-02-14
Love DouglasSale-5,782$5.54$32,0322024-02-14
Overdorf MichaelSale-1,349$5.53$7,4602024-02-14
Lew JenniferSale-1,809$5.54$10,0222024-02-14
Lew JenniferSale-1,057$3.84$4,0552024-01-23
Overdorf MichaelSale-978$3.84$3,7522024-01-23
Yednock TedDerivatives Exercise21,0002024-01-23
Yednock TedSale-22,057$3.84$84,6132024-01-23
Yednock TedSale-21,000$4.52$94,9662023-12-29
Yednock TedDerivatives Exercise21,0002023-12-29
Satter Muneer AOpen Market Purchase350,000$2.882023-12-28
Bain Capital Life Sciences Investors, LLCOpen Market Purchase300,000$2.132023-05-30
Yednock TedInitial2023-03-27
Overdorf MichaelGrant, award...etc18,9752023-02-21
Lew JenniferGrant, award...etc18,9752023-02-21
Love DouglasSale-6,571$5.87$38,5642023-02-17
Overdorf MichaelSale-1,645$6.3$10,3692023-02-15
Lew JenniferSale-1,908$6.31$12,0362023-02-15
Satter Muneer AOpen Market Purchase2,647,058$6.82023-02-14
ARTIS DEAN RICHARDInitial2023-01-12
Mattheakis LarryGrant, award...etc9,3762022-07-13
Lew JenniferGrant, award...etc9,3752022-07-13
Overdorf MichaelGrant, award...etc9,3752022-07-13
Satter Muneer AOpen Market Purchase2,453,988$3.842022-07-11
Love DouglasOpen Market Purchase60,000$2.452022-04-18
Keswani SanjayGrant, award...etc12,5002022-02-15
Mattheakis LarryGrant, award...etc12,5002022-02-15
Lew JenniferGrant, award...etc12,5002022-02-15
Love DouglasGrant, award...etc40,0002022-02-15
Overdorf MichaelGrant, award...etc12,5002022-02-15
Login to see more insider transactions
The information provided in this report about ANNX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Annexon, Inc
(NASDAQ:ANNX) 

ANNX stock logo

Annexon, Inc., a clinical-stage biopharmaceutical company, engages in developing therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its products in pipelines are focused on antibody-mediated autoimmune and complement-mediated neurodegenerative disorders....

Founded: 2011
Full Time Employees: 38
CEO: Douglas Love  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends